tafasitamab
Drug timelines are a Plus or Pro feature.
15 regulatory and trial events tracked for tafasitamab, covering 2020-01-30 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Epcoritamab With Lenalidomide and Tafasitamab in People With Diffuse Large B Cell Lymphoma [Phase 2]